{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:44:38Z","timestamp":1785811478996,"version":"3.56.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,10]]},"DOI":"10.7759\/cureus.12008","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T10:00:54Z","timestamp":1607594454000},"source":"Crossref","is-referenced-by-count":26,"title":["Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Mehak","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safeera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"GBD 2016 Dementia Collaborators","year":"2019","unstructured":"GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019, 18:88-106. 10.1016\/S1474-4422(18)30403-4","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2009.03.001","article-title":"2009 Alzheimer's disease facts and figures","volume":"5","author":"Alzheimer's Association","year":"2009","unstructured":"Alzheimer's Association. 2009 Alzheimer's disease facts and figures. Alzheimers Dement. 2009, 5:234-270. 10.1016\/j.jalz.2009.03.001","journal-title":"Alzheimers Dement"},{"key":"ref3","unstructured":"Degenerative diseases. Neuropathology. (1998). https:\/\/neuropathology-web.org."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers","volume":"88","author":"Reitz C","year":"2014","unstructured":"Reitz C, Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol. 2014, 88:640-651. 10.1016\/j.bcp.2013.12.024","journal-title":"Biochem Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001854","article-title":"Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease","volume":"11","author":"Martins IJ","year":"2006","unstructured":"Martins IJ, Hone E, Foster JK, et al.. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry. 2006, 11:721-736. 10.1038\/sj.mp.4001854","journal-title":"Mol Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2019.0200","article-title":"ApoE4-induced cholesterol dysregulation and its brain cell type-specific implications in the pathogenesis of Alzheimer's disease","volume":"42","author":"Jeong W","year":"2019","unstructured":"Jeong W, Lee H, Cho S, Seo J. ApoE4-induced cholesterol dysregulation and its brain cell type-specific implications in the pathogenesis of Alzheimer's disease. Mol Cells. 2019, 42:739-746. 10.14348\/molcells.2019.0200","journal-title":"Mol Cells"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9652","article-title":"Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels","volume":"252","author":"Kuo YM","year":"1998","unstructured":"Kuo YM, Emmerling MR, Bisgaier CL, Essenburg AD, Lampert HC, Drumm D, Roher AE. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem Biophys Res Commun. 1998, 252:711-715. 10.1006\/bbrc.1998.9652","journal-title":"Biochem Biophys Res Commun"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.0648","article-title":"Association of early-onset Alzheimer disease with elevated low-density lipoprotein cholesterol levels and rare genetic coding variants of APOB","volume":"76","author":"Wings TS","year":"2019","unstructured":"Wings TS, Cutler DJ, Wingo AP, et al.. Association of early-onset Alzheimer disease with elevated low-density lipoprotein cholesterol levels and rare genetic coding variants of APOB. JAMA Neurol. 2019, 76:809-817. 10.1001\/jamaneurol.2019.0648","journal-title":"JAMA Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001713","article-title":"Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis","volume":"11","author":"Proitsi P","year":"2014","unstructured":"Proitsi P, Lupton MK, Velayudhan L, et al.. Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis. PLoS Med. 2014, 11:1001713. 10.1371\/journal.pmed.1001713","journal-title":"PLoS Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2005.11.007","article-title":"Lipid metabolism in cognitive decline and dementia","volume":"51","author":"Panza F","year":"2006","unstructured":"Panza F, D'Introno A, Colacicco AM, et al.. Lipid metabolism in cognitive decline and dementia. Brain Res Rev. 2006, 51:275-292. 10.1016\/j.brainresrev.2005.11.007","journal-title":"Brain Res Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150734","article-title":"Cholesterol, 24-hydroxycholesterol, and 27-hydroxycholesterol as surrogate biomarkers in cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease: a meta-analysis","volume":"51","author":"Wang H","year":"2016","unstructured":"Wang H, Wang Y, Liu X, Kuo SH, Liu N, Song QY, Wang MW. Cholesterol, 24-hydroxycholesterol, and 27-hydroxycholesterol as surrogate biomarkers in cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease: a meta-analysis. J Alzheimers Dis. 2016, 51:45-55. 10.3233\/JAD-150734","journal-title":"J Alzheimers Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/09637486.2018.1508426","article-title":"Association between serum cholesterol levels and Alzheimer's disease in China: a case-control study","volume":"70","author":"Chen H","year":"2019","unstructured":"Chen H, Du Y, Liu S, Ge B, Ji Y, Huang G. Association between serum cholesterol levels and Alzheimer's disease in China: a case-control study. Int J Food Sci Nutr. 2019, 70:405-411. 10.1080\/09637486.2018.1508426","journal-title":"Int J Food Sci Nutr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2008.007214","article-title":"Plasma lipoprotein \u03b2-amyloid in subjects with Alzheimer's disease or mild cognitive impairment","volume":"45","author":"Mamo JCL","year":"2008","unstructured":"Mamo JCL, Jian L, James AP, Flicker L, Esselmann H, Wiltfang J. Plasma lipoprotein \u03b2-amyloid in subjects with Alzheimer's disease or mild cognitive impairment. Ann Clin Biochem. 2008, 45:395-403. 10.1258\/acb.2008.007214","journal-title":"Ann Clin Biochem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-111385","article-title":"Lipids and adipokines as risk factors for Alzheimer's disease","volume":"29","author":"Warren M","year":"2012","unstructured":"Warren M, Hynan L, Weiner M. Lipids and adipokines as risk factors for Alzheimer's disease. J Alzheimers Dis. 2012, 29:151-157. 10.3233\/JAD-2012-111385","journal-title":"J Alzheimers Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2004-6602","article-title":"Is there a characteristic lipid profile in Alzheimer's disease?","volume":"6","author":"Sabbagh M","year":"2004","unstructured":"Sabbagh M, Zahiri R, Ceimo J, Cooper K, Gaul W, Connor D, Sparks DL. Is there a characteristic lipid profile in Alzheimer's disease?. J Alzheimers Dis. 2004, 6:585-589. 10.3233\/JAD-2004-6602","journal-title":"J Alzheimers Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002886","article-title":"ABCA1-mediated cholesterol efflux capacity to cerebrospinal fluid is reduced in patients with mild cognitive impairment and Alzheimer's disease","volume":"5","author":"Yassine HN","year":"2016","unstructured":"Yassine HN, Feng Q, Chiang J, Petrosspour LM, Fonteh AN, Chui HC, Harrington MG. ABCA1-mediated cholesterol efflux capacity to cerebrospinal fluid is reduced in patients with mild cognitive impairment and Alzheimer's disease. J Am Heart Assoc. 2016, 5:002886. 10.1161\/JAHA.115.002886","journal-title":"J Am Heart Assoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms14011310","article-title":"Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers","volume":"14","author":"Kosicek M","year":"2013","unstructured":"Kosicek M, Hecimovic S. Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers. Int J Mol Sci. 2013, 14:1310-1322. 10.3390\/ijms14011310","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6:1000097. 10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol: long secret life behind a barrier","volume":"24","author":"Bj\u00f6rkhem I","year":"2004","unstructured":"Bj\u00f6rkhem I, Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol. 2004, 24:806-815. 10.1161\/01.ATV.0000120374.59826.1b","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2017.01.008","article-title":"Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers","volume":"13","author":"Wong MW","year":"2017","unstructured":"Wong MW, Braidy N, PoljakA, Pickford R, Thambisetty M, Sachdev PS. Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers. Alzheimers Dement. 2017, 13:810-827. 10.1016\/j.jalz.2017.01.008","journal-title":"Alzheimers Dement"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201439225","article-title":"Cholesterol in brain disease: sometimes determinant and frequently implicated","volume":"15","author":"Mart\u00edn MG","year":"2014","unstructured":"Mart\u00edn MG, Pfrieger F, Dotti CG. Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep. 2014, 15:1036-1052. 10.15252\/embr.201439225","journal-title":"EMBO Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00598","article-title":"Involvement of lipids in Alzheimer's disease pathology and potential therapies","volume":"11","author":"Chew H","year":"2020","unstructured":"Chew H, Solomon VA, Fonteh AN. Involvement of lipids in Alzheimer's disease pathology and potential therapies. Front Physiol. 2020, 11:598. 10.3389\/fphys.2020.00598","journal-title":"Front Physiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000070182.02537.84","article-title":"Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology","volume":"61","author":"Pappolla MA","year":"2003","unstructured":"Pappolla MA, Bryant-Thomas TK, Herbert D, et al.. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology. 2003, 61:199-205. 10.1212\/01.WNL.0000070182.02537.84","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00223","article-title":"Blood-based biomarkers for predictive diagnosis of cognitive impairment in a Pakistani population","volume":"12","author":"Iqbal G","year":"2020","unstructured":"Iqbal G, Braidy N, Ahmed T. Blood-based biomarkers for predictive diagnosis of cognitive impairment in a Pakistani population. Front Aging Neurosci. 2020, 12:223. 10.3389\/fnagi.2020.00223","journal-title":"Front Aging Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.08.003","article-title":"Association of blood lipids with Alzheimer's disease: a comprehensive lipidomics analysis","volume":"13","author":"Proitsi P","year":"2017","unstructured":"Proitsi P, Kim M, Whiley L, et al.. Association of blood lipids with Alzheimer's disease: a comprehensive lipidomics analysis. Alzheimers Dement. 2017, 13:140-151. 10.1016\/j.jalz.2016.08.003","journal-title":"Alzheimers Dement"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20289","article-title":"Serum lipids and hippocampal volume: the link to Alzheimer's disease?","volume":"56","author":"Wolf H","year":"2004","unstructured":"Wolf H, Hensel A, Arendt T, Kivipelto M, Winblad B, Gertz HJ. Serum lipids and hippocampal volume: the link to Alzheimer's disease?. Ann Neurol. 2004, 56:745-748. 10.1002\/ana.20289","journal-title":"Ann Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-012-0018-z","article-title":"Serum high-density lipoprotein cholesterol levels correlate well with functional but not with cognitive status in 85-year-old subjects","volume":"16","author":"Formiga F","year":"2012","unstructured":"Formiga F, Ferrer A, Chivite D, Pinto X, Badia T, Padr\u00f3s G, Pujol R. Serum high-density lipoprotein cholesterol levels correlate well with functional but not with cognitive status in 85-year-old subjects. J Nutr Health Aging. 2012, 16:449-453. 10.1007\/s12603-012-0018-z","journal-title":"J Nutr Health Aging"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00532","article-title":"Physical exercise may increase plasma concentration of high-density lipoprotein-cholesterol in patients with Alzheimer's disease","volume":"14","author":"Jensen CS","year":"2020","unstructured":"Jensen CS, Musaeus CS, Frikke-Schmidt R, et al.. Physical exercise may increase plasma concentration of high-density lipoprotein-cholesterol in patients with Alzheimer's disease. Front Neurosci. 2020, 14:532. 10.3389\/fnins.2020.00532","journal-title":"Front Neurosci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.66.3.343","article-title":"Contribution of vascular risk factors to the progression in Alzheimer disease","volume":"66","author":"Helzner EP","year":"2009","unstructured":"Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol. 2009, 66:343-348. 10.1001\/archneur.66.3.343","journal-title":"Arch Neurol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2005.06.015","article-title":"Circulating biomarkers of cognitive decline and dementia","volume":"364","author":"Solfrizzi V","year":"2006","unstructured":"Solfrizzi V, D'Introno A, Colacicco AM, et al.. Circulating biomarkers of cognitive decline and dementia. Clin Chim Acta. 2006, 364:91-112. 10.1016\/j.cca.2005.06.015","journal-title":"Clin Chim Acta"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1159\/000361043","article-title":"Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender","volume":"38","author":"Hall JR","year":"2014","unstructured":"Hall JR, Wiechmann AR, Johnson LA, et al.. Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender. Dement Geriatr Cogn Disord. 2014, 38:300-309. 10.1159\/000361043","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-016-0320-6","article-title":"Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study","volume":"15","author":"He Q","year":"2016","unstructured":"He Q, Li Q, Zhao J, Wu T, Ji L, Huang G, Ma F. Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study. Lipids Health Dis. 2016, 15:146. 10.1186\/s12944-016-0320-6","journal-title":"Lipids Health Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000256368.57375.b7","article-title":"Serum cholesterol changes after midlife and late-life cognition, Twenty-one-year follow-up study","volume":"68","author":"Solomon A","year":"2007","unstructured":"Solomon A, K\u00e5reholt I, Ngandu T, et al.. Serum cholesterol changes after midlife and late-life cognition, Twenty-one-year follow-up study. Neurology. 2007, 68:751-756. 10.1212\/01.wnl.0000256368.57375.b7","journal-title":"Neurology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160826","article-title":"Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis","volume":"56","author":"Anstey KJ","year":"2017","unstructured":"Anstey KJ, Ashby-Mitchell K, Peters R. Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis. J Alzheimers Dis. 2017, 56:215-228. 10.3233\/JAD-160826","journal-title":"J Alzheimers Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10060386","article-title":"Cholesterol and Alzheimer's disease risk: a meta-meta-analysis","volume":"10","author":"S\u00e1iz-Vazquez O","year":"2020","unstructured":"S\u00e1iz-Vazquez O, Puente-Mart\u00ednez A, Ubillos-Landa S, Pacheco-Bonrostro J, Santab\u00e1rbara J. Cholesterol and Alzheimer's disease risk: a meta-meta-analysis. Brain Sci. 2020, 10:386. 10.3390\/brainsci10060386","journal-title":"Brain Sci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.3.254","article-title":"Low-density lipoprotein cholesterol and the risk of dementia with stroke","volume":"282","author":"Moroney JT","year":"1999","unstructured":"Moroney JT, Tang M, Berglund L, et al.. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA. 1999, 282:254-260. 10.1001\/jama.282.3.254","journal-title":"JAMA"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00005","article-title":"Low-density lipoprotein cholesterol and Alzheimer's disease: a systematic review and meta-analysis","volume":"12","author":"Zhou Z","year":"2020","unstructured":"Zhou Z, Liang Y, Zhang X, et al.. Low-density lipoprotein cholesterol and Alzheimer's disease: a systematic review and meta-analysis. Front Aging Neurosci. 2020, 12:5. 10.3389\/fnagi.2020.00005","journal-title":"Front Aging Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2019.1571633","article-title":"Prediction of Alzheimer's disease with serum lipid levels in Asian individuals: a meta-analysis","volume":"24","author":"Wu Y","year":"2019","unstructured":"Wu Y, Wang Z, Jia X, et al.. Prediction of Alzheimer's disease with serum lipid levels in Asian individuals: a meta-analysis. Biomarkers. 2019, 24:341-351. 10.1080\/1354750X.2019.1571633","journal-title":"Biomarkers"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146554","article-title":"Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: a meta-analysis study","volume":"1727","author":"Liu Y","year":"2020","unstructured":"Liu Y, Zhong X, Shen J, et al.. Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: a meta-analysis study. Brain Res. 2020, 1727:146554. 10.1016\/j.brainres.2019.146554","journal-title":"Brain Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009436","article-title":"Serum triglycerides in Alzheimer disease: relation to neuroimaging and CSF biomarkers","volume":"94","author":"Bernath M","year":"2020","unstructured":"Bernath M, Bhattacharyya S, Nho K, et al.. Serum triglycerides in Alzheimer disease: relation to neuroimaging and CSF biomarkers. Neurology. 2020, 94:2088-2098. 10.1212\/WNL.0000000000009436","journal-title":"Neurology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.12.007","article-title":"Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease","volume":"86","author":"Popp J","year":"2013","unstructured":"Popp J, Meichsner S, K\u00f6lsch H, et al.. Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease. Biochem Pharmacol. 2013, 86:37-42. 10.1016\/j.bcp.2012.12.007","journal-title":"Biochem Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2017.1369566","article-title":"Plasma lipids metabolism in mild cognitive impairment and Alzheimer's disease","volume":"20","author":"Costa AC","year":"2019","unstructured":"Costa AC, Joaquim HPG, Forlenza O, Talib LL, Gattaz WF. Plasma lipids metabolism in mild cognitive impairment and Alzheimer's disease. World J Biol Psychiatry. 2019, 20:190-196. 10.1080\/15622975.2017.1369566","journal-title":"World J Biol Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-3-200208060-00006","article-title":"Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease","volume":"137","author":"Kivipelto M","year":"2002","unstructured":"Kivipelto M, Helkala EL, Laakso MP, et al.. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002, 137:149-155. 10.7326\/0003-4819-137-3-200208060-00006","journal-title":"Ann Intern Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-012-0018-z","article-title":"Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years","volume":"264","author":"Toro P","year":"2014","unstructured":"Toro P, Degen C, Pierer M, Gustafson D, Schr\u00f6der J, Sch\u00f6nknecht P. Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years. Eur Arch Psychiatry Clin Neurosci. 2014, 264:485-492. 10.1007\/s12603-012-0018-z","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1177\/1533317514531443","article-title":"Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis","volume":"29","author":"Agarwal R","year":"2014","unstructured":"Agarwal R, Tripathi CB. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis. Am J Alzheimers Dis Other Demen. 2014, 29:575-582. 10.1177\/1533317514531443","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2006.08.048","article-title":"Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease","volume":"408","author":"Raygani AV","year":"2006","unstructured":"Raygani AV, Rahimi Z, Kharazi H, Tavilani H, Pourmotabbed T. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease. Neurosci Lett. 2006, 408:68-72. 10.1016\/j.neulet.2006.08.048","journal-title":"Neurosci Lett"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1999.tb00724.x","article-title":"Increased apolipoprotein B serum concentration in Alzheimer's disease","volume":"100","author":"Caramelli P","year":"1999","unstructured":"Caramelli P, Nitrini R, Maranh\u00e3o R, Louren\u00e7o AC, Damasceno MC, Vinagre C, Caramelli B. Increased apolipoprotein B serum concentration in Alzheimer's disease. Acta Neurol Scand. 1999, 100:61-63. 10.1111\/j.1600-0404.1999.tb00724.x","journal-title":"Acta Neurol Scand"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.09.016","article-title":"A complex association between ABCA7 genotypes and blood lipid levels in Southern Chinese Han patients of sporadic Alzheimer's disease","volume":"382","author":"Li H","year":"2017","unstructured":"Li H, Zhou J, Yue Z, et al.. A complex association between ABCA7 genotypes and blood lipid levels in Southern Chinese Han patients of sporadic Alzheimer's disease. J Neurol Sci. 2017, 382:13-17. 10.1016\/j.jns.2017.09.016","journal-title":"J Neurol Sci"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.6.5.683","article-title":"Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease","volume":"6","author":"Lukiw WJ","year":"2014","unstructured":"Lukiw WJ. Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease. Expert Rev Neurother. 2014, 6:683-693. 10.1586\/14737175.6.5.683","journal-title":"Expert Rev Neurother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/44978-plasma-lipids-as-biomarkers-for-alzheimers-disease-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:28Z","timestamp":1707506488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/44978-plasma-lipids-as-biomarkers-for-alzheimers-disease-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.12008","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,10]]}}}